| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |